Helix Therapeutics LLC is categorized under Commercial Biotechnical Research in New Haven, CT and active since 2006.
Helix Therapeutics LLC was established in 2006, and today employs 1 to 4, earning Unknown per year. This is a Commercial Biotechnical Research business, which does work in the B2B market, and is classified as a Commercial Biotechnical Research, under code number 5419100 by the NAICS.
If you are seeking more information, feel free to contact Joseph Catino, Chief Executive Officer at the company’s single location by writing to 150 Munson St, New Haven, Connecticut CT 06511 or by phoning (203) 772-2888. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Helix Therapeutics LLC |
| Contact Person: | Joseph Catino, Chief Executive Officer |
| Address: | 150 Munson St, New Haven, Connecticut 06511 |
| Phone Number: | (203) 772-2888 |
| Annual Revenue (USD): | Unknown |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Biotechnical Research |
| SIC Code: | 8731 |
| NAICS Code: | 5419100 |
| Share This Business: |
Helix Therapeutics LLC was started in 2006 to provide professional Commercial Biotechnical Research under the SIC code 8731 and NAICS code 5419100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Joseph Catino, Chief Executive Officer for inquiries that concern Helix Therapeutics LLC by calling the company number (203) 772-2888, as your correspondence is most welcome. Additionally, the physical location of the single location of Helix Therapeutics LLC can be found at the coordinates 41.32144,-72.92888 as well as the street address 150 Munson St in New Haven, Connecticut 06511.
For its online presence, you may visit Helix Therapeutics LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.